search
Back to results

Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline

Primary Purpose

Age-related Cognitive Decline, Age-related Physiology Decline

Status
Active
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Multi-domain intervention
Sponsored by
National Yang Ming University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Age-related Cognitive Decline focused on measuring frailty, cognitive impairment, physio-cognitive decline syndrome, dementia, biomarkers, skeletal muscle, aging, neuroimaging, multidomain intervention

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: aged ≥ 65 years slow gait speed (<1 m/s in 6-meter walk test) or weakness (dominant handgrip strength <28 kg in men, <18 kg in women) subjective cognitive declines Exclusion Criteria: established diagnosis of dementia, Parkinsonism or other mobility-limiting conditions active diseases receiving treatment, such as cancer, heart failure, COPD and so on estimated life expectancy <12 months current nursing home residents

Sites / Locations

  • Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Usual care group

Multidomain intervention group

Arm Description

Provide conventional health educations in every three-month interval

The multidomain intervention program is designed as structural training sessions of 2-hour training sessions two times per week.

Outcomes

Primary Outcome Measures

Change in MRI study
Change in MRI study from baseline to 12 months in all participants
Change in Physical performance
Change in hand-grip strength (kg), six-meter walking speed (m/s) from baseline to 12 months in all participants

Secondary Outcome Measures

Life quality SF12
measured by the 12-Item Short Form Health Survey (SF-12).
Change in Complete blood count
Change in Complete blood count from baseline to 12 months in all participants
Change in Nutrition intake
measured by Mini-nutritional assessment questionnaire. ranged 0-30, higher values represent a better condition
Change in depression
measured by the Center for Epidemiological Studies-Depression (CES-D) ranged 0-60, higher values represent a worse condition
Change in cognitive ability
Change in cognitive function measure by MoCA ranged 0-30, MMSE ranged 0-30, higher values represent a better condition
Change in International Physical Activity Questionnaire (IPAQ)
Change in physical activity measured by IPAQ, indicates that spent being physically active than the prior 7 days.There are no established thresholds for presenting MET-minutes, the IPAQ Research Committee proposes that reported as comparisons of median values and interquartile ranges for different populations from baseline to 12 months in all participants. The higher values represent a better activity.
Change in Vitamin D3 25-OH
Change in Vitamin D3 25-OH concentration from baseline to 12 months in all participants
Change in DHEA-S
Change in DHEA-S concentration from baseline to 12 months in all participants
Change in IGF-1
Change in IGF-1 concentration from baseline to 12 months in all participants
Change in Homocysteine
Change in Homocysteine concentration from baseline to 12 months in all participants
Change in hs-CRP
Change in hs-CRP concentration from baseline to 12 months in all participants
Change in Zinc
Change in Zinc concentration from baseline to 12 months in all participants
Change in TSH
Change in TSH concentration from baseline to 12 months in all participants
Change in Myostatin
Change in Myostatin concentration from baseline to 12 months in all participants
Change in Activing A
Change in Activing A concentration from baseline to 12 months in all participants
Change in Follistatin
Change in Follistatin concentration from baseline to 12 months in all participants
Change in Relative appendicular skeletal muscle index (RASM)
Change in RASM from baseline to 12 months in all participants
Change in body fat %
Change in body fat % from baseline to 12 months in all participants

Full Information

First Posted
April 13, 2023
Last Updated
June 19, 2023
Sponsor
National Yang Ming University
Collaborators
National Science and Technology Council
search

1. Study Identification

Unique Protocol Identification Number
NCT05828043
Brief Title
Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline
Official Title
Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 1, 2021 (Actual)
Primary Completion Date
July 30, 2023 (Anticipated)
Study Completion Date
July 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Yang Ming University
Collaborators
National Science and Technology Council

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main goal is to develop an enhanced intervention program that can persistently maintain intervention effects with measurement of clinical characteristics, phenotypic features, together with biochemical profiles, myokines, proteomics, metabolomics brain imaging, and our previous findings of exosomal miRNA and to correlate changes of the biomarkers to neuroimaging. The linkage between both positive (irisin) and negative regulators (myostatin, miR-29b-3p) with structural brain imaging by a randomized controlled trial is the key novelty with strongest evidence strength in human study.
Detailed Description
This study is a randomized controlled trial of 12-month multidomain intervention program among community-living older adults with early physical or cognitive impairments. Inclusion criteria are: (1) community-dwelling adults aged ≥ 65 years, (2) slow gait speed (<1 m/s in 6-meter walk test) or weakness (dominant handgrip strength <28 kg in men, <18 kg in women), (3) subjective cognitive declines; subjects with the following conditions will be excluded: (1) established diagnosis of dementia, Parkinsonism or other mobility-limiting conditions, (2) active diseases receiving treatment, such as cancer, heart failure, COPD and so on, (3) estimated life expectancy <12 months, (4) current nursing home residents.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Age-related Cognitive Decline, Age-related Physiology Decline
Keywords
frailty, cognitive impairment, physio-cognitive decline syndrome, dementia, biomarkers, skeletal muscle, aging, neuroimaging, multidomain intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
102 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual care group
Arm Type
No Intervention
Arm Description
Provide conventional health educations in every three-month interval
Arm Title
Multidomain intervention group
Arm Type
Experimental
Arm Description
The multidomain intervention program is designed as structural training sessions of 2-hour training sessions two times per week.
Intervention Type
Behavioral
Intervention Name(s)
Multi-domain intervention
Intervention Description
Each session comprises of 45 minutes physical fitness activities targeting on muscle strength, balance, and flexibility; 1-hour cognitive training primarily on reasoning and memory exercises; and 15-minute for nutritional advices based on national diet guidelines for older adults
Primary Outcome Measure Information:
Title
Change in MRI study
Description
Change in MRI study from baseline to 12 months in all participants
Time Frame
baseline, 12 month
Title
Change in Physical performance
Description
Change in hand-grip strength (kg), six-meter walking speed (m/s) from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Secondary Outcome Measure Information:
Title
Life quality SF12
Description
measured by the 12-Item Short Form Health Survey (SF-12).
Time Frame
baseline, 6, 12 month
Title
Change in Complete blood count
Description
Change in Complete blood count from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Nutrition intake
Description
measured by Mini-nutritional assessment questionnaire. ranged 0-30, higher values represent a better condition
Time Frame
baseline, 6, 12 month
Title
Change in depression
Description
measured by the Center for Epidemiological Studies-Depression (CES-D) ranged 0-60, higher values represent a worse condition
Time Frame
baseline, 6, 12 month
Title
Change in cognitive ability
Description
Change in cognitive function measure by MoCA ranged 0-30, MMSE ranged 0-30, higher values represent a better condition
Time Frame
baseline, 6, 12 month
Title
Change in International Physical Activity Questionnaire (IPAQ)
Description
Change in physical activity measured by IPAQ, indicates that spent being physically active than the prior 7 days.There are no established thresholds for presenting MET-minutes, the IPAQ Research Committee proposes that reported as comparisons of median values and interquartile ranges for different populations from baseline to 12 months in all participants. The higher values represent a better activity.
Time Frame
baseline, 6, 12 month
Title
Change in Vitamin D3 25-OH
Description
Change in Vitamin D3 25-OH concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in DHEA-S
Description
Change in DHEA-S concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in IGF-1
Description
Change in IGF-1 concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Homocysteine
Description
Change in Homocysteine concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in hs-CRP
Description
Change in hs-CRP concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Zinc
Description
Change in Zinc concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in TSH
Description
Change in TSH concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Myostatin
Description
Change in Myostatin concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Activing A
Description
Change in Activing A concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Follistatin
Description
Change in Follistatin concentration from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in Relative appendicular skeletal muscle index (RASM)
Description
Change in RASM from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month
Title
Change in body fat %
Description
Change in body fat % from baseline to 12 months in all participants
Time Frame
baseline, 6, 12 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: aged ≥ 65 years slow gait speed (<1 m/s in 6-meter walk test) or weakness (dominant handgrip strength <28 kg in men, <18 kg in women) subjective cognitive declines Exclusion Criteria: established diagnosis of dementia, Parkinsonism or other mobility-limiting conditions active diseases receiving treatment, such as cancer, heart failure, COPD and so on estimated life expectancy <12 months current nursing home residents
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liang-Kung Chen, M.D., PhD
Organizational Affiliation
Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University
Official's Role
Study Director
Facility Information:
Facility Name
Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University
City
Taipei
ZIP/Postal Code
112
Country
Taiwan

12. IPD Sharing Statement

Learn more about this trial

Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline

We'll reach out to this number within 24 hrs